Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1979
Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone
T Talseth, K D Haegele, J L McNay, et al.
Journal of Chromatography
|
January 4, 1980
Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine
K D Haegele, H B Skrdlant, T Talseth, et al.
Transplantation Proceedings
|
June 1, 1988
Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients
K J Berg, G Nordby, K Rootwelt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1982
Endogenous generation of hydralazine from labile hydralazine hydrazones
W A Clementi, J L McNay, T Talseth, et al.
Lancet (London, England)
|
July 20, 1985
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
K P Nordal, T Talseth, E Dahl, et al.
Nephron
|
January 1, 1989
Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
K J Berg, A Gjellestad, G Nordby, et al.
Transplantation Proceedings
|
February 1, 1990
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
D Albrechtsen, K J Berg, I Brekke, et al.
Transplantation Proceedings
|
June 1, 1988
Short-term changes in renal function of the remaining kidney after donor nephrectomy
H Holdaas, A Hartmann, T Talseth, et al.
Kidney International
|
May 1, 1986
Long-term blood pressure and renal function in kidney donors
T Talseth, P Fauchald, S Skrede, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
March 1, 1992
Fifteen years' experience with renal transplantation in systemic amyloidosis
A Hartmann, H Holdaas, P Fauchald, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1979
Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone
T Talseth, K D Haegele, J L McNay, et al.
Journal of Chromatography
|
January 4, 1980
Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine
K D Haegele, H B Skrdlant, T Talseth, et al.
Transplantation Proceedings
|
June 1, 1988
Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients
K J Berg, G Nordby, K Rootwelt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1982
Endogenous generation of hydralazine from labile hydralazine hydrazones
W A Clementi, J L McNay, T Talseth, et al.
Lancet (London, England)
|
July 20, 1985
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
K P Nordal, T Talseth, E Dahl, et al.
Nephron
|
January 1, 1989
Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
K J Berg, A Gjellestad, G Nordby, et al.
Transplantation Proceedings
|
February 1, 1990
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
D Albrechtsen, K J Berg, I Brekke, et al.
Transplantation Proceedings
|
June 1, 1988
Short-term changes in renal function of the remaining kidney after donor nephrectomy
H Holdaas, A Hartmann, T Talseth, et al.
Kidney International
|
May 1, 1986
Long-term blood pressure and renal function in kidney donors
T Talseth, P Fauchald, S Skrede, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
March 1, 1992
Fifteen years' experience with renal transplantation in systemic amyloidosis
A Hartmann, H Holdaas, P Fauchald, et al.
Page
of 9